Full Length Research Paper
References
|
Abdul AB, Abdelwahab SI, Al-Zubairi AS, Elhassan MM, Murali SM (2008).Anticancer and Antimicrobial Activities of Zerumbone from the Rhizomes of Zingiber zerumbet. International Journal of Pharmacology 4(4):301-304. |
|
|
Carter RB (1991). Differentiating analgesic and non-analgesic drug activitiers on rat hot plate: effect of behavioral endpoint. Pain 47(2):211-220. |
|
|
Correa CR, Calixto JB (1993). Evidence for participation of Bi and B2 kinin receptors in formalin-induced nociceptive response in mouse. British Journal of Pharmacology 110(1):193-198. |
|
|
Chien TY, Huang SK, Lee CJ, Tsai PW, Wang CC (2016). Antinociceptive and Anti-Inflammatory Effects of Zerumbone against Mono-Iodoacetate-Induced Arthritis. International Journal of Molecular Sciences 17(2):249 |
|
|
Dai JR, Cardellina JH, McMohan JB, Boyd MR (1997). Zerumbone, an HIV innibitory cytotoxic sesquiterpene of Zengiber aromaticum and Zingiber zerumbet. Natural Product Letter 10(2):115-118. |
|
|
Dev S (1960). Studies in sesquiterpenes-XVI. Zerumbone, a monocyclic sesquiterpene ketone. Tetrahedron 8(3-4):171-180. |
|
|
Eddy NB, Leimback D (1987). Synthetic analgesics: II. Dithienylbutenyl- and dithienylbutylamines. Journal Pharmacology Experimental Therapy 107(3):385-393. |
|
|
Heapy CG, Jamieson A, Russell NJW (1987). Afferent C-fibre and A delta activity in models of inflammation. British Journal Pharmacology 90:164-166. |
|
|
Hunskaar S, Fasmer OB, Hole K (1985). Formalin test in mice, auseful techniqu for evaluation mild analgeia. Journal of Neuroscience Methods 14(1):69-76 |
|
|
Hunskaar S, Hole K (1987). The formalin test in mice: dissociation between inflammatory and non - inflammatory pain. Pain 30(1):103-114. |
|
|
Hwang AS, Wilcox GL (1987). Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain 28(3):343-355. |
|
|
Julius D, Basbaum AI (2001). Molecular mechanisms of nociception. Nature 413(6852):203-210. |
|
|
Kitayama TK, Yamamoto R, Utsumi M, Takatani RK, Hill Y, Kawai S, Sawada, Okamoto T (2001). Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives. Bioscience Biotechnology Biochemistry 65(10):2193-2199. |
|
|
Koshimizu K, Ohigashi H, Tokuda H, Kondo A, Yamaguchi K (1988). Election of plants edible of meeting to the activity promoting antitumor. The Cancer Letters 39:247-257. |
|
|
Koster R, Andersons MD, Debeer EJ (1959). Acetic Acid Analgesic Screening. Federation Proceedings 18:412-417. |
|
|
Lapa AJ, Valle JR, Rezende AM, Ribeiro FB, Neto AA (2003). Methods of Evaluation of the Pharmacological Activity of Medicinal Plants. São Paulo Editor, 220 p. |
|
|
MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM, Alnemri ES (1997). Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. Journal Biological Chemistry 272(41):25417-25420. |
|
|
Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A, Nakamura Y, Jiwajinda S, Terao J, Ohigashi H (2002). Zerumbone, a Southeast Asian ginger sesquiterpene, markedly supresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α,β- unsaturated carbonyl group is a prerequisite. Carcinogenesis 23(5):795-802. |
|
|
Murakami A, Tanaka T, Lee JY, Surh YJ, Kim HW, Kawabata K, Nakamura Y, Jiwajinda S, Ohigashi H (2004). Zerumbone a sesquiterpene in subtropical ginger suppresses skin tumor initiation and promotion stages in ICR mice. International Journal of Cancer 110(4):481-490. |
|
|
Perimal EK, Akhtar MN, Mohamad AS, Khalid MH, Ming OH, Khalid S, Tatt LM, Kamaldin MN, Zakaria ZA, Israf DA, Lajis N, Sulaiman MR (2011). Zerumbone-induced antinociception: Involvement of the L-arginine-nitric oxide-cGMP-PKC-K+ATP channel pathways. Basic & Clinical Pharmacology and Toxicology 108:155162. |
|
|
Pinheiro CCS (2005). Process of obtaining zerumbona isolated from the essentialoils of root of Zingiber zerumbet (l.). Request for national patent depository PI0505343-9. |
|
|
Pinheiro CCS (2009). Process and potential analgesic, anti-inflammatory and pre-zerumbona clinictoxicity retrieved from Zingiber Zerumbet (l.) smith (Zingiberaceae), Doctoral thesis presented to Universidade Federal doAmazonas – UFAM. Postgraduate course in biotechnologymulti-institutional xiv, 119 p. |
|
|
Rocha E, Silva M (1968). Statistical methods applied to Pharmacology. ch. 3. in: Fundamentals of Pharmacology and its applications to Therapeutics - volume1, 2a ed. Edart, Livraria, Editora Ltda., São Paulo. |
|
|
Salustiano JK, Hocino E,Carlini EA (1996). Effects of Cannabis sativa and chlorpromazine on mice as measured by two methods used for evaluation of tranquilizing agents. Medical Pharmacology Experimental 15:153-162. |
|
|
Somchit MN, Shukriyah MH, Bustamam AA, Zuraini A (2005). Anti-pyretic and analgesic activity of Zingiber zerumbet. International Journal of Pharmacology 1(3):277-280. |
|
|
Sulamain MR, Perimal EK, Zakaria ZA, Mokhtar F, Akhtar MN, Lajis NH, Israf DA (2009). Preliminary analysis of the antinociceptive activity of zerumbone. Fitoterapia 80:230-232. |
|
|
Sulamain MR, Tengku Mohamad TA, Shaik Mossadeq WM, Moin S, Yusof M, Mokhtar AF, Zakaria ZA, Israf DA, Lajis N (2010). Antinociceptive activity of the essential oil of Zingiber zerumbet. Planta Medica 76(2):107-112. |
|
|
Takada Y, Murakami A, Aggarwal BB (2005). Zerumbone abolishes NF-κB and IκBα kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis and downregulation of invasion. Oncogene 24(46):6957-6969. |
|
|
Yob NJ, Jofrry SM, Affandi MM, Teh LK, Salleh MZ, Zakaria ZA (2011). Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evidence-Based Complementary and Alternative Medicine 543216. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
